NCT00212719View on ClinicalTrials.gov

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

April 30, 2006

Conditions
Involutional Osteoporosis
Interventions
DRUG

ONO-5920

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY